Implanted neuroprosthesis improves walking ability in stroke patient

June 1, 2016

Left: multichannel implantable gait-assist system. Right: participant walking with the system. (credit: N.S. Makowski et al./Am. J. Phys. Med. Rehabil.)

A surgically implanted neuroprosthesis has led to substantial improvement in walking speed and distance in a patient with limited mobility after a stroke, according to a single-patient study in the American Journal of Physical Medicine & Rehabilitation.

The system, programmed to stimulate coordinated activity of hip, knee, and ankle muscles, “is a promising intervention to provide assistance to stroke survivors during daily walking,” write Nathaniel S. Makowski, PhD, and colleagues of the Louis Stokes Cleveland Veterans Affairs Medical Center.

With technical refinements and further research, such implanted neuroprosthesis systems might help to promote walking ability for at least some patients with post-stroke disability.

Clinically relevant gait improvements

The researchers report their experience with an implanted neuroprosthesis in a 64-year-old man with impaired motion and sensation of his left leg and foot after a hemorrhagic (bleeding) stroke. After thorough evaluation, he underwent surgery to place an implanted pulse generator and intramuscular stimulating electrodes in seven muscles of the hip, knee, and ankle.*

Makowski and colleagues then created a customized electrical stimulation program to activate the muscles, with the goal of restoring a more natural gait pattern. The patient went through extensive training in the researchers’ laboratory for several months after neuroprosthesis placement.

With training without muscle stimulation, gait speed only increased from 0.29 meters per second (m/s) before surgery, to 0.35 m/s after training, a non-significant improvement. But when muscle stimulation was turned on, gait speed increased dramatically: to 0.72 m/s, with “more symmetrical and dynamic gait.”

In addition, the patient was able to walk much farther. When first evaluated, he could walk only 76 meters before becoming fatigued. After training but without stimulation, he could walk about 300 meters (in 16 minutes). With stimulation, the patient’s maximum walking distance increased to more than 1,400 meters (in 41 minutes) with stimulation.

Even though the patient wasn’t walking with stimulation outside the laboratory, his walking ability in daily life improved significantly. He went from “household-only” ambulation to increased walking outside in the neighborhood.

“The therapeutic effect is likely a result of muscle conditioning during stimulated exercise and gait training,” according to the authors. “Persistent use of the device during walking may provide ongoing training that maintains both muscle conditioning and cardiovascular health.”

While the results of this initial experience in a single patient are encouraging, the researchers emphasize that large-scale studies will be needed to demonstrate the wider applicability of a neuroprosthesis for multi-joint control. If the benefits are confirmed, Makowski and colleagues conclude, “daily use of an implanted system could have significant clinical relevance to a portion of the stroke population.”

* Tensor fasciae latae (hip flexor), sartorius (hip and knee flexor), gluteus maximus (hip extensor), short head of biceps femoris (knee flexor), quadriceps (knee extensor), tibialis anterior/peroneus longus (ankle dorsiflexors), and gastrocnemius.


Abstract of Improving Walking with an Implanted Neuroprosthesis for Hip, Knee, and Ankle Control After Stroke.

Objective: The objective of this work was to quantify the effects of a fully implanted pulse generator to activate or augment actions of hip, knee, and ankle muscles after stroke.

Design: The subject was a 64-year-old man with left hemiparesis resulting from hemorrhagic stroke 21 months before participation. He received an 8-channel implanted pulse generator and intramuscular stimulating electrodes targeting unilateral hip, knee, and ankle muscles on the paretic side. After implantation, a stimulation pattern was customized to assist with hip, knee, and ankle movement during gait.

The subject served as his own concurrent and longitudinal control with and without stimulation. Outcome measures included 10-m walk and 6-minute timed walk to assess gait speed, maximum walk time, and distance to measure endurance, and quantitative motion analysis to evaluate spatial-temporal characteristics. Assessments were repeated under 3 conditions: (1) volitional walking at baseline, (2) volitional walking after training, and (3) walking with stimulation after training.

Results: Volitional gait speed improved with training from 0.29 m/s to 0.35 m/s and further increased to 0.72 m/s with stimulation. Most spatial-temporal characteristics improved and represented more symmetrical and dynamic gait.

Conclusions: These data suggest that a multijoint approach to implanted neuroprostheses can provide clinically relevant improvements in gait after stroke.